Brief: Medical Developments International Sees FY25 Underlying EBIT To Be Improved On FY24
Oct 22 (Reuters) - Medical Developments International
Ltd MVP.AX :
* SEES FY25 UNDERLYING EBIT TO BE STRONGLY IMPROVED ON FY24
Further company coverage: MVP.AX
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Medical Developments International
See all newsBrief: Medical Developments International Reports Group Revenue For Q1 FY27 Of A$10.2 Million
Brief: Medical Developments International Says CEO Brent MacGregor Intends To Step Down
Australia's Medical Developments International gains on higher annual revenue
Brief: Medical Developments International Logs FY Full Revenue A$42.6 Million
Medical Developments International soars on robust quarterly revenue